Fig. 4From: Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three yearsAdjusted survival curves representing time to first atypical femur fracture over ten years for women who interrupt BP in the first three years (Short-term) and those who continue BP treatment for a minimum of 3 years (Longer-term)Back to article page